Trial Profile
Phase I/II trial of 4SC-208
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 23 Jan 2018
Price :
$35
*
At a glance
- Drugs 4SC 208 (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 23 Jan 2018 New trial record